Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1963 1
1964 2
1965 3
1966 1
1968 1
1969 2
1971 2
1972 1
1973 2
1974 1
1975 2
1977 1
1978 4
1980 3
1983 4
1984 4
1985 2
1986 2
1987 4
1988 6
1989 5
1992 4
1993 2
1994 4
1995 5
1996 11
1997 8
1998 5
1999 3
2000 3
2001 10
2002 8
2003 9
2004 10
2005 16
2006 14
2007 10
2008 8
2009 10
2010 11
2011 5
2012 7
2013 7
2014 8
2015 9
2016 5
2017 17
2018 13
2019 15
2020 26
2021 17
Text availability
Article attribute
Article type
Publication date

Search Results

313 results
Results by year
Filters applied: . Clear all
Page 1
Enhanced tumor response to radiotherapy after PD-1 blockade in metastatic gastric cancer.
Sasaki A, Nakamura Y, Togashi Y, Kuno H, Hojo H, Kageyama S, Nakamura N, Takashima K, Kadota T, Yoda Y, Mishima S, Sawada K, Kotani D, Kawazoe A, Kuboki Y, Taniguchi H, Kojima T, Doi T, Yoshino T, Yano T, Kobayashi T, Akimoto T, Nishikawa H, Shitara K. Sasaki A, et al. Among authors: takashima k. Gastric Cancer. 2020 Sep;23(5):893-903. doi: 10.1007/s10120-020-01058-4. Epub 2020 Mar 16. Gastric Cancer. 2020. PMID: 32180056
Beyond Binaries: Dissolving the Empirical/Normative Divide.
Chan S, Cunningham-Burley S, de Togni G, Erikainen S, Sethi N, Takashima K. Chan S, et al. Among authors: takashima k. AJOB Empir Bioeth. 2020 Jan-Mar;11(1):17-19. doi: 10.1080/23294515.2020.1722290. AJOB Empir Bioeth. 2020. PMID: 32096722 Free PMC article. No abstract available.
A novel cyclohexene derivative, ethyl (6R)-6-[N-(2-Chloro-4-fluorophenyl)sulfamoyl]cyclohex-1-ene-1-carboxylate (TAK-242), selectively inhibits toll-like receptor 4-mediated cytokine production through suppression of intracellular signaling.
Ii M, Matsunaga N, Hazeki K, Nakamura K, Takashima K, Seya T, Hazeki O, Kitazaki T, Iizawa Y. Ii M, et al. Among authors: takashima k. Mol Pharmacol. 2006 Apr;69(4):1288-95. doi: 10.1124/mol.105.019695. Epub 2005 Dec 22. Mol Pharmacol. 2006. PMID: 16373689
RIOK3 keeps MDA5 inactive.
Takashima K, Oshiumi H, Seya T. Takashima K, et al. Oncotarget. 2015 Oct 13;6(31):30423-4. doi: 10.18632/oncotarget.5265. Oncotarget. 2015. PMID: 26415216 Free PMC article. No abstract available.
313 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page